At closeAs of Aug 12, 2026
Compare

Halozyme Therapeutics, Inc.

HALO
HealthcareBiotechnologyNASDAQ
At closeAs of Aug 12, 2026
$101.79-0.81%
$12.07BMarket cap
27.68xP/E ratio
3.48MVolume (24h)
Compare
HealthcareBiotechnologyNASDAQ

Halozyme Therapeutics, Inc. (HALO) has no dividend history on record - it doesn't currently pay a dividend.